Overview

Confirmatory Study Nepafenac 0.3%

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study was to assess the safety and efficacy of an investigational eye drop intended for the prevention and treatment of inflammation (swelling and redness) and pain in the eye after cataract extraction.

Phase:

Phase 3

Details

Lead Sponsor:

Alcon Research

Treatments:

Nepafenac